PD-L1 assessment in lung cancer biopsies—pitfalls and limitations
The programmed cell death-ligand 1 (PD-L1) protein expression on tumor cells predicts the efficacy of immunotherapy in patients with non-small cell lung cancer. However, the assessment of PD-L1 expression on tumor cells has limited power for selecting patients for immunotherapy due to intra-tumoral...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2024-03-01
|
| Серія: | The International Journal of Biological Markers |
| Онлайн доступ: | https://doi.org/10.1177/03936155231214273 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|